Diagnosis and Treatment of Tourette Syndrome
Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Amphetamines and Related Agents
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Cocaine
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Energy Drinks and Caffeine-Related Adverse Effects
JAMA 309:243-244,297, Sepkowitz, K., 2013
Adult Attention Deficit - Hyperactivity Disorder
NEJM 369:1935-1944, Volkow, N.D. & Swanson, J.M., 2013
Clinicopathologic Conference, Methcathinone (Bath Salts) Intoxication
NEJM 369:2536-2545, Case 40-2013, 2013
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008
The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
Improvement of Gait by Chronic, High Doses of Methylphenidate in Patients with Advanced Parkinsons Disease
JNNP 78:470-475, Devos,D.,et al, 2007
ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006
Attention-deficit Hyperactivity Disorder
Lancet 366:237-248, Biederman,J. &Faraone,S., 2005
Herbal Energy Drinks, Phenylpropanoid Compounds, and Cerebral Vasculopathy
Neurol 65:1137-1138, Worrall,B.B.,et al, 2005
Attention Deficit Hyperactivity Disorder in Adulthood
JNNP 75:523-525, Toone,B., 2004
Attention-Deficit/Hyperactivity Disorder in Adults
JAMA 292:619-623, Wilens,T.E.,et al, 2004
Evidence Based Management of Attention Deficit Hyperactivity Disorder
BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Problems in the Management of Attention-Deficit-Hyperactivity Disorder
NEJM 340:40-46, Zametkin,A.J.&Ernst,M., 1999
Treatment of Attention-Deficit-Hyperactivity Disorder
NEJM 340:780-788, Elia,J.,et al, 1999
Attention-Deficit Hyperactivity Disorder and Hyperkinetic Disorder
Lancet 351:429-433, 3871998., Swanson,J.M.,et al, 1998
Methylphenidate in Early Poststroke Recovery:A Double-Blind, Placebo-Controlled Study
Arch Phys Med Rehabil 79:1047-1050, Grade,C.,et al, 1998
Treatment Modalities for Narcolepsy
Neurol 50:S43-S48, Fry,J.M., 1998
Medication for Children with Attentional Disorders
Pediatrics 98:301-304, Perrin,J.,et al, 1996
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
The Medical Letter, 36:109-1101994., , 1994
Psychotropic Drugs and Sleep
BMJ 306:1331-1334, Eisen,J.,et al, 1993
Attention-Deficit Hyperactivity Disorder in Adults
Clinical Therapeutics 14:138-147, Bellak,L.&Black,R.B., 1992
Girls with Fragile X Syndrome:Physical and Neurocognitive Status and Outcome
Pediatrics 89:395-400, Hagerman,R.J.,et al, 1992
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
Psychostimulants in Post-Stroke Depression
J Neuropsychiatry Clin Neurosci 3:23-27, Masand,P.,et al, 1991
Narcolspey
NEJM 323:389-394, Aldrich,M.S., 1990
Side Effects of Methylphenidate in Children with Attention Deficit Hyperactivity Disorder
Pediatrics 86:184-192, Barkley,R.A.,et al, 1990
Methylphenidate-induced Chorea:Case Report & Pharmacologic Implications
Neurol 28:1041-1044, Weiner,W.J.,et al, 1978
The Effect of Central Nervous System Stimulants on Tourette Syndrome
Ann Neurol 2:69, Golden,G.S., 1977
Treating Problem Children with Stimulant Drugs
NEJM 289:407, Sroufe,L.A.,et al, 1973
Depression of Growth in Hyperactive Children on Stimulant Drugs
NEJM 287:217, 1972; 287:249972., Safer,D.,et al, 1972
Amphetamine Abuse
The New Physician, July 1970, p. 591., Swanke,W., 1970
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Intranasal Selectracetam in a Patient with Reading Epilepsy:First-In-Human Use to Prevent Reflex Seizures
Ann Neurol 99:535-539, Koepp,M.J.,et al, 2026
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings
AJNR 47:513-520, Bruen,R.,et al, 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Iatrogenic Cerebral Amyloid Angiopathy after Cardiac Surgery, Two Case Reports
Neurol 106:e214819, Brunet de Courssou,J-B.,et al, 2026